Physician-patient communication in rheumatology: a systematic review by Georgopoulou, S. et al.
              
City, University of London Institutional Repository
Citation: Georgopoulou, S., Prothero, L. ORCID: 0000-0002-5385-0397 and D'Cruz, D. P. 
(2018). Physician-patient communication in rheumatology: a systematic review. 
Rheumatology International, 38(5), pp. 763-775. doi: 10.1007/s00296-018-4016-2 
This is the published version of the paper. 
This version of the publication may differ from the final published 
version. 
Permanent repository link:  https://openaccess.city.ac.uk/id/eprint/26003/
Link to published version: http://dx.doi.org/10.1007/s00296-018-4016-2
Copyright and reuse: City Research Online aims to make research 
outputs of City, University of London available to a wider audience. 
Copyright and Moral Rights remain with the author(s) and/or copyright 
holders. URLs from City Research Online may be freely distributed and 
linked to.
City Research Online:            http://openaccess.city.ac.uk/            publications@city.ac.uk
City Research Online
Vol.:(0123456789) 
Rheumatology International (2018) 38:763–775 
https://doi.org/10.1007/s00296-018-4016-2
SYSTEMATIC REVIEW
Physician–patient communication in rheumatology: a systematic 
review
Sofia Georgopoulou1,2 · Louise Prothero2 · David P. D’Cruz2,3
Received: 13 February 2018 / Accepted: 19 March 2018 / Published online: 26 March 2018 
© The Author(s) 2018
Abstract
The nature of physician–patient interaction can have a significant impact on patient outcomes through information-sharing 
and disease-specific education that can enhance patients’ active involvement in their care. The aim of this systematic review 
was to examine all the empirical evidence pertaining to aspects of physician–patient communication and its impact on patient 
outcomes. A systematic search of five electronic databases (MEDLINE, PsycINFO, EMBASE, CINAHL, and Web of Sci-
ence) was undertaken from earliest record to December 2016. Studies were eligible if they: (1) included adult participants 
(18 years or over) with a diagnosis of a rheumatic condition; (2) were of quantitative, qualitative or mixed methods design; 
(4) were surveys, observational and interventional studies; (5) were published in the English language; and (6) reported 
findings on either various physician–patient communication aspects alone or in combination with physical and psychological 
outcomes. Searches identified 455 papers. Following full-text retrieval and assessment for eligibility and quality, ten studies 
were included in the review; six quantitative, one mixed methods, and three qualitative papers. Higher levels of trust in the 
physician and active patient participation in the medical consultation were linked to lower disease activity, better global 
health, less organ damage accrual, greater treatment satisfaction with fewer side effects from the medication, more positive 
beliefs about control over the disease, and about current and future health. Future research could focus on the design and 
implementation of interventions incorporating communications skills and patient-education training.
Keywords Physician–patient communication · Doctor–patient interaction · Rheumatic diseases · Patient outcomes
Introduction
Physician–patient communication is a central clinical func-
tion that is complex in nature and has received increased 
attention in recent years. The main goals of the interac-
tion between doctor and patient are: information sharing to 
support diagnosis and treatment, relationship building and 
disease-specific education. In this process, doctors’ commu-
nication style, attitudes, beliefs, and perceptions can influ-
ence the relationship dynamic and enhance patients’ active 
involvement in their care which may lead to improved out-
comes [1, 2].
Studies involving patients with rheumatic diseases sug-
gest that the quality of communication with doctors is linked 
to patient outcomes. For instance, Fawole et al. reported that 
the nature of physician–patient interactions in the assess-
ment and management of patients with rheumatic diseases 
can have a significant impact on patients’ health-related 
quality of life (HRQoL) [2]. One of the domains that can 
be affected by the quality of contact with the health care 
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provider and the amount of information provided to patients 
by the quality of this interaction is medication adherence [3]. 
Medication adherence ranges between 30–99% in patients 
with rheumatic diseases and is multifactorial [4]. Physician 
behaviour can have a considerable impact on relationship 
building and development of trust with patients which can 
affect adherence [5]. If there is lack of concordance and trust 
in the physician and insufficient information, the likelihood 
of the patient being non-adherent to the medication is high 
[6] increasing the risk for greater disease activity, flares and 
organ damage. Education level and medication side effects 
can also affect medication adherence [7].
Additional factors that can have a significant impact on 
patient outcomes particularly on their risk of cardiovascular 
disease (CVD) include traditional and lifestyle risk factors 
such as smoking, hypertension, hypercholesterolemia, dia-
betes, and physical inactivity [8, 9]. Existing literature is 
indicative of the fact that inflammatory rheumatic diseases 
are linked to an increased risk of cardiovascular disease 
(CVD) [10] with fatal and nonfatal CVD being higher in 
patients with RA and SLE compared to the general popula-
tion. A healthy lifestyle such as following a balanced diet, 
stopping smoking, losing weight, and increasing physical 
activity levels can, therefore, decrease the risk of CVD in 
these conditions. Communicating this effectively to patients 
and supporting them in modifying aspects of their lifestyle 
requires that the relationship between doctor and patient be 
characterised by trust and good rapport [11]. Communica-
tion is vital to patients’ understanding of their illness and 
the risks and benefits associated with its treatment [12] and 
a vital component in developing and maintaining a relation-
ship that involves support, empathy, understanding [13], 
good collaboration [14], and patient-centred interviewing 
all of which can enhance outcomes such as adherence, diet, 
smoking cessation, and physical activity levels.
Although there have been reviews on physician–patient 
communication, they generally refer to the topic across dif-
ferent conditions and do not focus exclusively on rheumatic 
diseases [15, 16]. In addition, they are narrative reviews 
rather than systematic reviews and they were conducted 
over a decade ago [16, 17]. This highlighted the need for 
a review to systematically identify and appraise the litera-
ture on doctor–patient communication with a specific focus 
on patients with rheumatic diseases. Data on the quality of 
interaction between patients and clinicians in rheumatol-
ogy could identify potential factors that can be addressed to 
improve communication—if the evidence suggests a need 
for it. As a second step, based on the review findings, the 
ground could be set for the design and implementation of 
a project that could explore the efficacy of an intervention 
involving training rheumatology health care professionals 
in motivational interviewing (MI) with the aim to enhance 
communication with their patients and improve outcomes.
The current review aimed to systematically identify, 
appraise and evaluate the evidence on: (a) factors influenc-
ing physician–patient communication and (b) the association 
between doctor–patient interaction and health outcomes.
Methods
Search strategy
Literature searches and the design of the current article were 
both performed according to previously published recom-
mended considerations for writing a narrative biomedical 
review to maximise the robustness and impact of this review 
[18]. Thus, a systematic electronic search of peer-reviewed 
studies published in the English language from inception 
to December 2016 was undertaken in five standard bib-
liographic databases (MEDLINE, PsycINFO, EMBASE, 
CINAHL, and Web of Science) using combinations and 
MESH terms of the following keywords : rheumatic dis-
ease, systemic lupus erythematosus, rheumatology, patient 
physician interaction, work alliance, patient–physician com-
munication, physician–patient relationship, provider–patient 
relationship, doctor patient relationship, or doctor–patient 
communication, provider–patient communication, patient 
outcomes, health-related quality of life, and well-being 
(Table 1). Reference lists of relevant included papers were 
further screened for additional relevant studies that might 
have been missed by the electronic database searches.
Eligibility criteria
Observational or interventional studies of qualitative, quan-
titative or mixed-method design or RCTs examining physi-
cian–patient communication and associated outcomes for 
adult patients (≥ 18 years) with all kinds of rheumatic dis-
eases, published in English in peer-reviewed journals were 
considered for inclusion (Table 2). No limitations were made 
regarding clinical outcomes.
Table 1  Search strategy overview
Databases searched
MEDLINE, EMBASE, PsycINFO, CINAHL, Web of Science
 Rheumatic disease/ or systemic lupus erythematosus/ or SLE/ or 
rheumatology/ or rheum* (incl. MESH terms/exploding terms)
 Patient physician interaction/ or work alliance/ or patient–physician 
communication/ or physician–patient relationship/ or provider–
patient relationship/ or doctor patient relationship/ or doctor–
patient communication/ or provider–patient communication
 Patient outcomes/ or health-related quality of life/ or well-being
 1 and 2
 1 and 2 and/or 3
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Exclusion criteria
Unpublished data in the form of conference abstracts and 
university theses were excluded from the review.
Selection of studies
Identified papers were screened for eligibility by the pri-
mary author (SG) based on title and abstracts followed by 
reference screening of studies that were deemed eligible. 
After full-text retrieval, additional, independent review of 
the included papers by the authors (LP and DPD’C) was per-
formed to confirm compliance with study inclusion criteria. 
Consensus was used to resolve differences.
Data extraction and management
Study data were extracted by the primary review author (SG) 
using a predesigned data extraction form on the following 
details: (1) aim; (2) country; (3) design and methods; (4) 
sample size and diagnosis; (5) description of communica-
tion/patient outcome variables; and (6) conclusions (see 
Tables 3, 4).
Assessment of quality of reporting 
and methodological quality
Two different instruments were used to assess methodologi-
cal quality of the studies due to the inclusion of both quanti-
tative and qualitative papers in the current review to provide 
a robust evaluation.
The Newcastle–Ottawa Quality Assessment Scale 
(NOS) [19] adapted for cross-sectional studies [20] was 
selected to assess quality of the quantitative studies. A 
total score based on the degree of appropriateness of the 
research design, recruitment strategy and response rate, 
representativeness of participants, objectivity/reliability of 
outcome measures, power calculations, and appropriate-
ness of statistical analyses was computed to assess meth-
odological quality.
The adapted for cross-sectional studies NOS contains 
seven items, categorized into three dimensions (selection, 
comparability, and outcome). For each item, a series of 
response options is provided allowing to score a maximum 
total of ten stars for assessment of study quality across all 
questions.
The Critical Appraisals Skills Programme (CASP) cri-
teria [21] was chosen as a quality assessment instrument 
for the qualitative studies due to its inclusivity in address-
ing different aspects of study quality, including methodo-
logical and theoretical aspects [22]. Its broad checklist-
type quality criteria offer a flexible way to assess rigour, 
credibility and relevance despite the heterogeneous nature 
of included studies. Studies are evaluated based on con-
gruency between the paradigm, methodology and method, 
the influence of the researcher on the research, data col-
lection and data analysis. A maximum of 100% can be 
scored across ten questions each of which includes a series 
of response options which need to have been addressed in 
the study.
Independent assessment of the risk of bias of each of 
the included studies was undertaken by two reviewers (SG 
& LP). Each study was classified as “excellent”, “good”, 
“acceptable”, or “weak” based on the total methodological 
quality assessment score which was the sum of individual 
domains scores (see Tables 5, 6). Score disagreements 
were discussed and resolved by consensus through allo-
cation of a final agreed rating for each study which was 
confirmed by the third reviewer (DPD’C).
Table 2  Inclusion criteria
Inclusion criteria (general)
 Types of studies
  Qualitative or quantitative studies
  Observational studies or RCTs
 Types of participants
  Adult patients with one or more rheumatic disease(s) of either non-inflammatory nature (e.g., fibromyalgia syndrome) or of inflammatory 
nature (e.g., RA, SLE, AS) or both
Inclusion criteria (specific)
 Communication
  Studies exploring (and reporting statistical results—if applicable) aspects of communication or interaction between physician and patient 
such as trust, decision-making, explanation, education, knowledge, respect, understanding, patient involvement and participation etc
AND/OR
 Outcomes
  Studies assessing outcomes such as (but not limited to) disease activity, morbidity, psychological/physical status, medication adherence, 
organ damage, treatment satisfaction associated with physician–patient communication components





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The searches identified 455 publications. 21 of these were 
examined in full text, of which ten studies [23–32] met 
the inclusion criteria (Fig. 1). Excluded studies were due 
to lack of fulfilment of eligibility criteria. Four of the 
excluded articles [33–35] were conference abstracts and 
published full-text papers were not available, two were 
literature reviews [16, 36], four did not assess communica-
tion or outcome variables [37–40], and one was a descrip-
tion of educational programmes efficacy regarding patients 
with rheumatoid arthritis [17]. Quality criteria were met 
with ‘excellent’ mean quality assessment scores for both 
quantitative and qualitative studies (8.4* and 95%, respec-
tively) (see Tables 5, 6).
Overall description of included studies
The characteristics of the included studies are shown in 
Tables 3 and 4. The studies were published between 2003 
and 2013. Six were of quantitative design, three were qual-
itative and one employed mixed methods. The majority 
of the quantitative studies [23–27] were conducted in the 
USA, whereas one was done in Japan [28]. The qualitative 
studies took place in Sweden [29], Norway [30] and the 
UK [31], while the mixed-method study was conducted in 
the USA [32].
Description of quantitative studies
Two main themes emerged from the quantitative papers that 
were identified in this review: (a) the factors associated with 
better communication between physicians and patients and 
(b) the impact of the quality of this interaction on patient 
outcomes.
Overall, based on the evidence from the identified 
papers, it appeared that: (a) greater patient participation, 
shared decision-making, treatment satisfaction and trust in 
the physician were associated with better communication 
between physician and patient [23, 25, 28]. Higher quality 
physician–patient communication, in turn, was associated 
with better global health, less organ damage, lower disease 
activity, and fewer medication side effects [23–28].
Patients who participated more actively in their interac-
tion with physicians tended to have less permanent organ 
damage [25]. The authors reported a dose–response rela-
tionship with the average of the SLICC/ACR Damage Index 
decreasing by 7% for every additional one-point increase 
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CI 0.91–0.94; p < 0.0001). Although the analysis was cross-
sectional, the study had longitudinal components suggesting 
a possibility that active communication may affect the devel-
opment of future complications in patients with SLE. Ward 
et al. emphasized that socioeconomic status (SES) could not 
explain this association, since it was correlated neither with 
participatory communication (education level: r = − 0.08; 
p = 0.49; Hollingshead Index: r = 0.00; p = 0.99) nor with 
physician patient-centred communication (education level: 
r = − 0.10; p = 0.37; Hollingshead Index: r = 0.05; p = 0.69).
Street et al. [43] reported that what seemed to have been 
associated with increased patient participation in interac-
tions with physicians was more frequent engagement in 
partnership building (adj. mean = 3.36; 95% CI 2.02–4.69; 
p < 0.01) and supportive talk on behalf of the physician 
(adj. mean = 1.41; 95% CI 0.49–2.33; p < 0.01) in patients 
with SLE. The authors highlighted the fact that a variety of 
contextual as well as patient and clinician factors could be 
linked to the quality of the interaction. Clinician communi-
cation style and the clinical setting such as time allotted for 
the consultation were predictive of patient participation in 
medical consultations [23].
The impact of increased patient participation in the 
medical consultation was described by Ishikawa et al. [28]. 
Patients with RA who were more active participants reported 
feelings of being understood by the physician (r = 0.36; 
p < 0.001) and increased shared decision-making was linked 
to better physician–patient communication [28]. However, 
feelings of being understood depended on patients’ decision-
making preferences. For example, patients who were more 
autonomous in decision-making reported feelings of being 
understood if they were more active in the consultation, 
while patients who had lower preference for decision-making 
did not (preference × participation: β = 0.089, SE = 0.030; 
p = 0.021). The authors suggested that these findings may be 
influenced by Japanese culture, since Japanese patients are 
more focused on seeking information to build rapport with 
the physician rather than making decisions [41].
Beusterien et  al. [24] reported that positive physi-
cian–patient interactions led to higher satisfaction with 
treatment regimen and feeling well-controlled (t = 6.10), 
less depressed (t = 7.19) and more favourable perceptions 
of current health (t = 4.07) [24]. Goal-setting, in particular 
was associated with being more hopeful about future health 
in patients with SLE (t = 3.02).
Freburger et  al. [26] found that lower levels of trust 
in physicians were linked to poorer health (r = − 0.10; 
p < 0.05). Patients reported having fairly high levels of 
trust in rheumatologists (mean = 76.25; SD = 13.29). This, 
however, was dependent on the condition that patients had. 
For example, patients with FM and osteoarthritis (OA) had 
less trust in their rheumatologist than patients with RA 
(β = − 4.58; p < 0.001 and β = − 3.66; p = 0.003) [26]. Other 
variables such as older age (r = − 0.129; p = 0.002), minor-
ity status (r = 2.708; p = 0.05), and higher education level 
(r = − 0.332; p = 0.047) were also associated with lower 
levels of trust in physicians.
According to Berrios-Rivera et al. [27], increased trust 
but also additional components of the medical interaction 
such as informativeness, patient-centredness, sensitivity 
to patient concerns, and disclosure of information were 
correlated with fewer side effects (r = − 0.30; p < 0.005; 
r = − 0.27; p < 0.05; r = − 0.24; p < 0.05; r = − 0.29; 
p < 0.05) and better global health (r = 0.20; p < 0.05), respec-
tively. Results in patients with RA and SLE also showed 
that the association between trust and medical care inter-
action was moderate (6.2–7.1) regarding patient–doctor 
communication, which was suggestive of the involvement 
of the other components. Communication that focused on 
the patient was related to patient disclosure of information 
(B = 0.38; p < 0.001) which, in turn, was negatively associ-
ated with disease activity (B = − 0.20; p = 0.03) [27]. The 
authors emphasized that in patients with RA and SLE, eth-
nicity was an important factor associated with trust in phy-
sicians (African-American: B = − 0.64; p = 0.005; Latino: 
B = − 0.29; p = 0.001).
Table 5  Overview of quality assessment scores—cross-sectional 
studies (Newcastle–Ottawa Scale—NOS)
*Quality Assessment Categories: <  5 (weak); 5–6.5 (acceptable); 
6.6–8 (good); 8.1–10 excellent
Authors Mean NOS Score 




Street et al. [23] 8.5* (8* and 9*) Excellent
Beusterien et al. [24] 5.5* (5* and 6*) Acceptable
Ward et al. [25] 10* (10* and 10*) Excellent
Freburger et al. [26] 9* (9* and 9*) Excellent
Ishikawa et al. [28] 8.5* (8* and 9*) Excellent
Berrios-Rivera et al. [27] 8* (8* and 8*) Good
Koneru et al. [32] 9* (9* and 9*) Excellent
Table 6  Overview of quality assessment scores—qualitative studies 
(Critical Appraisals Skills Programme—CASP)
*Quality Assessment Categories: <  50 (weak); 50–65 (acceptable); 
66–80 (good); 81–100 (excellent)
Authors Mean CASP Score 




Ahlmén et al. [29] 91% (90 and 92%) Excellent
Haugli et al. [30] 96% (98 and 94%) Excellent
Chambers et al. [31] 98% (98 and 98%) Excellent
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Description of qualitative studies
The three qualitative papers [29–31] and the one mixed-
method study [32] included in this review could be classi-
fied into two thematic categories: (a) important outcomes 
of treatment and of the medical consultation [29, 30] and 
(b) factors associated with medication intake relative to the 
nature of physician–patient communication [31, 32].
Ahlmén et al. [29] conducted focus groups with patients 
who had RA. A number of themes emerged from the inter-
views such as: “normal life”, “physical capacity”, “independ-
ence”, and “well-being”. Patient aims included regaining full 
health and having a normal life without limitations and not 
be considered as different by people because of their condi-
tion and associated disability. “Physical capacity” referred to 
patients’ loss of functionality and improvement in symptoms 
such as fatigue, pain and stiffness, muscle strength were rea-
sons to make them feel happy. Patients wanted to be able to 
be independent and manage daily activities such as personal 
hygiene, walking and dressing as well as work and social 
activities. “Well-being” was a concept that patients could 
not clearly define but was rated as an important outcome 
in terms of feeling happy, enjoying life and regaining self-
confidence. Satisfaction with treatment was linked to quality 
of communication between rheumatology staff and patients, 
which was regarded as a pre-requisite for effective treatment. 
A good relationship with the clinician was also related to 
mutual respect and trust. Patients expected all clinicians to 
be experts in RA but wanted to be accepted as experts on 
their own bodies, which made it possible for them to “take 
charge” of their lives [29].
Haugli et al. [30] interviewed two groups of patients: one 
with well-defined inflammatory conditions such as RA or 
ankylosing spondylitis (AS) and one with non-inflammatory 
conditions such as FM. The relationship with their doctor 
was rated as important by patients in both groups. Two cen-
tral themes emerged from the interviews: patients wanted 
“to be seen” and “to be believed”. For RA and AS patients, 
this meant to be seen as an individual and not as a mere 
diagnosis, and to be believed as far as pain and suffering was 
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concerned. “To be seen” also had implications for the physi-
cian’s ability to take into consideration the perspective of the 
patient and to provide them with sufficient information about 
the condition and the prognosis. “Being believed” also sug-
gested that the doctor acknowledged patients’ expert knowl-
edge and the jointly agreed development of a treatment plan. 
For FM patients, both themes referred to being able to obtain 
a useful somatic diagnosis. According to patients, receiv-
ing a diagnosis meant being believed, because “no objec-
tive findings” implied no “real” disease which was associ-
ated with patients feeling that they were mistrusted by the 
physician. Getting the right diagnosis was also interlinked 
with the necessary investigations, appropriate treatment, 
and information provision regarding the disease. Reciprocal 
trust, availability of the physician, and receiving adequate 
information about the disease and the diagnosis were fur-
ther concepts mentioned. All patient groups reported that 
the relationship with their doctor was important in the care 
of their health problems [30].
Chambers et al. [31] interviewed patients with SLE to 
explore reasons for medication adherence. The reasons cited 
by patients for taking their medications were: (a) fear of 
worsening disease especially in patients who had experi-
enced life-threatening episodes of SLE; (b) the belief that 
there was no other effective therapeutic alternative to West-
ern medicines; (c) lack of knowledge about SLE to allow 
confidence in changing medications due to its complexity; 
and (d) feelings of moral obligation or responsibility to 
others such as family and health care workers for investing 
time in their care. Themes for not taking SLE medications 
included: (a) attempting to test whether they were able to 
control the disease without drugs, due to the belief that SLE 
could and should be controlled with alternative methods; 
(b) the belief that long-term use of drugs was unnecessary 
especially in patients who were well and stable; (c) fear of 
adverse effects of medications; (d) practical difficulties in 
obtaining medications such as pharmacy delay in filling the 
prescription; and (e) poor communication with doctors, for 
example the physician’s way of introducing new medica-
tions to patients, their sensitivity to patients’ questions and 
concerns, clarity of instructions and frequency of follow-up 
[31].
Risk factors for medication non-adherence in patients 
with SLE were investigated by Koneru et al. [32] through 
patient interviews and medical records review. Results indi-
cated modest adherence to medications: 61% to prednisone, 
49% to hydroxychloroquine, and 57% to immunosuppres-
sants. Risk factors for non-adherence included single status 
(hydroxychloroquine: χ2 = 4.48; p = 0.03; OR = 9.10; 95% CI 
1.10–70.3; R2 = 36%), low educational level (hydroxychlo-
roquine: χ2 = 4.21; p = 0.04; OR = 5.20; 95% CI 1.14–24.0), 
complicated medication regimens, limited comprehension 
of physician explanations and instructions (prednisone: 
χ2 = 10.70; p = 0.001; OR = 26.20; 95% CI 7.30–95; 
R2 = 48%; hydroxychloroquine: χ2 = 6.90; p = 0.008; 
OR = 17.30; 95% CI 4.30–69; R2 = 53%) and having to take 
medications more than once daily. A busy lifestyle, forget-
ting to take the medications or running out of them, and not 
being at home were the main barriers to adherence reported. 
In contrast, patients cited pill boxes, tasks lists and better 
explanation of the rationale of the prescribed medication 
regimens were most helpful for adhering to medication [32].
Discussion
The goal for this systematic review was to appraise the evi-
dence identified from published articles relating to physi-
cian–patient communication in rheumatology and associ-
ated outcomes. The number of papers included in the review 
was small due to relatively limited published research with 
a focus on this particular topic. The data suggested that 
factors associated with doctor–patient communication are 
distinguished into two categories: (a) more active and posi-
tive patient participation in a medical consultation is asso-
ciated with improved outcomes such as less organ damage, 
lower disease activity, feelings of being understood, fewer 
medication side effects, perceptions that the illness is well-
controlled, increased decision-making, physician partnership 
building and supportive talk, greater treatment satisfaction 
and more positive beliefs about current and future health and 
(b) higher levels of trust in the physician are linked to better 
global health, fewer treatment side effects and lower disease 
activity and increased disclosure of information.
Current results provide some evidence that the quality 
of communication is linked to improved health outcomes 
possibly through increased patient participation and trust. 
For example, one of the most vital health outcomes included 
organ damage the risk of which is increased with medication 
non-adherence. As Ward et al. [25] reported, patients who 
participated more actively in their interaction with physi-
cians tended to have less permanent organ damage which 
was inversely related in a dose-dependent fashion to more 
active participation [25]. Patients who were more actively 
involved in the consultation might have been more likely to 
obtain information that could have decreased the likelihood 
of their non-adherence to prescribed medication. For exam-
ple, greater participation in their care might provide patients 
with a deeper understanding of ways of the necessity, and 
side effects of their medication as well as ways to control 
their condition beyond pharmaceutical agents as Chambers 
et al. [31] highlighted. In addition, patients who did not 
have much trust in their physician were more likely to report 
poorer health [26], while physicians expressing sensitivity to 
patient concerns and focusing on patient-centredness tended 
to be linked to fewer medication side effect and better global 
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health [27]. All of these findings are consistent with previ-
ous research in the area which showed that rheumatology 
patients’ HRQoL can be influenced by the nature of their 
interaction with their physician [2] including the amount of 
information provided and its association with medication 
adherence [3].
Identifying the pathways through which communication 
influences health and well-being particularly in patients with 
rheumatic diseases is vital to understand why it may lead to 
better or worse health outcomes. In general, there are two 
pathways of influence: (a) the direct route, for example, 
when physician’s behaviour validates the patient’s perspec-
tive and expresses empathy for them. This may help a patient 
experience improved psychological well-being, i.e., less fear 
or anxiety [42] and (b) the indirect or mediated route, where 
health status or intermediate outcomes such as adherence, 
self-management skills or social support could be influenced 
by mediating factors including satisfaction with care, moti-
vation to adhere to treatment, trust in the clinician, clini-
cian–patient agreement, and shared understanding [1]. Sup-
port and clear explanations of disease-related information 
such as prognosis, treatment options and side effects could 
improve a particular health outcome, for instance, disease 
activity through increasing patient trust and understanding 
which, in turn, might facilitate adherence with the prescribed 
therapy. Naturally, other factors would need to be considered 
as well when assessing pathways of influence in communica-
tion such as educational level or race [43].
A review by Haskard Zolnierek and DiMatteo [6] showed 
that training physicians across a variety of specialities in 
communication skills resulted in substantial and significant 
improvement in patient adherence with the odds of patient 
adherence being 1.62 times higher when a physician is 
trained compared to receiving no training [6]. One of the 
techniques frequently used to support patients in behaviour 
change is Motivational Interviewing (MI). MI is a patient-
centred counselling technique [44] that can be applied to 
address key components of long-term disease management 
such as coping strategies, self-management, medication 
adherence and can be delivered as part of routine care by a 
patient’s health care professional [45, 46]. A meta-analysis 
by Rubak et al. [47] showed that MI was superior to tradi-
tional advice-giving in the treatment of a broad range of 
behavioural problems and diseases. Moreover, both psychol-
ogists and physicians obtained an effect in approximately 
80% of the studies, while other healthcare providers obtained 
an effect in 46% of the studies [47].
The primary limitation of this review is the inability to 
combine the results of studies with varied designs (quali-
tative, quantitative and mixed methods), interventions, 
surveys, observational studies, and outcome measures. 
Particularly, the field of communication research, due to 
its complex nature, is characterised by a lack of consensus 
on what to measure [48]. The cross-sectional design of 
most included studies also prevented establishing causal 
effects between variables. Moreover, the number of the 
papers included was not sufficient to allow for strong con-
clusions to be drawn. This review might also be subject to 
a slightly higher risk of bias as it had not been pre-regis-
tered on PROSPERO. Finally, the majority of quantitative 
studies were conducted in the US where the health care 
system is different to models followed in other countries 
which suggests findings may not be generalisable to other 
populations.
The lack of more robust evidence and a greater number 
of studies prevents us from reaching strong conclusions. 
However, based on the included articles, it can be specu-
lated that patient participation, in concert with greater 
informational and emotional support provided by the rheu-
matologist might increase patients’ involvement in their 
care as well as trust in their doctor which could result in 
improved outcomes. This would be beneficial for patients, 
because they might experience better quality of life due to 
decreased disease activity and organ damage but it may 
also be cost-effective for the NHS in the long-term due 
to decreased need for frequent appointments. However, 
more research is needed to increase our understanding of 
the dynamics of doctor–patient communication and its 
impact on outcomes. Thus, future studies could focus on 
targeting the key elements described in this review and 
exploring their pathways of influence. Their findings could 
then be used to inform the design and implementation of 
appropriate interventions, for instance, physician training 
in patient-centred counselling techniques such as Motiva-
tional Interviewing [44].
To conclude, the current systematic review provides 
some evidence in support of the importance of the quality 
of communication between rheumatologists and patients 
and their relationship to outcomes such as quality of life, 
medication adherence, and disease activity. Overall, better 
interaction between the two parties was linked to improved 
outcomes such as lower disease activity and organ damage, 
treatment satisfaction and fewer side effects. The two key 
elements identified in the included studies as maintaining 
a central role in this were patient participation in the medi-
cal consultation and trust in the physician.
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